Search results for: 'pulp ad part'
- Did you mean
- pfl1 ad pfrt
- p2l4 ad pfrt
- Related search terms
- part 01 00 00 00
- parts 01 00 00 00
- part market growth
- part solutions in the global hydrogen production market
- parts solutions in the global hydrogen production market
-
22 Jun 2020  |  North America  |  Technology Research
Analysing Sepsis Management Part I: Diagnosis
Recent Advances in Sepsis Diagnosis: PCR, Immunoassays, Sequencing and beyond
Sepsis diagnosis The current research study discusses the understanding of sepsis, its epidemiology, sepsis diagnosis and unmet clinical need of rapid sepsis diagnosis, existing and developing diagnostic platforms for sepsis management including patents landscape, clinical studies, Regional analysis, companies and their sepsis diagnostic platforms...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Nov 2020  |  Global  |  Technology Research
Analysing Sepsis Management Part II: Treatments
Recent developments in Sepsis Treatment focused towards antibiotics, inhibitors, antibodies, peptides, recombinant proteins, antibacterial, antifungal, antivirals, vaccines, and probiotics
Sepsis is a life-threatening condition caused by overactivation of host immune system upon infections which may lead to organ failure and potentially death. World Health Organization designates sepsis as a global public health priority. Several studies conducted to understand the molecular basis of sepsis, septic shock, and organ failure. Despite e...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Sep 2019  |  Global  |  Technology Research
Emerging Therapeutics for Neurodegenerative Diseases Part II: Huntington's Disease and Amyotrophic Lateral Sclerosis (HD & ALS)
Novel Targeted Therapeutic Strategies Technologies Around Neurodegenerative Disorders - From Palliative to Future Interventions
At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Aug 2020  |    |  Technology Research
Data Science Impacting the Pharmaceutical Industry Part II: Clinical trial Applications
Enabling faster analysis using advanced tools
Clinical Trials, the most crucial step in drug discovery has never been in the forefront in adopting new technologies and transforming from the conventional protocols. With the development of AI/ML in the last five years, it has opened up a new horizon for transforming clinical trials. It has been proven that use of AI/ML tools can scan through la...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Aug 2019  |  Global  |  Technology Research
Emerging Therapeutics for Neurodegenerative Diseases, Part I: Novel Targeted Therapeutic Strategies Technologies for Alzheimer's and Parkinson's Diseases
Novel Targeted Therapeutic Strategies Technologies Around Neurodegenerative Disorders - From Palliative to Future Interventions
At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Aug 2020  |  Global  |  Technology Research
Data Science Impacting the Pharmaceutical Industry
Part I: Drug Discovery Applications
Data science and AI have the potential to transform drug discovery in terms of costs, speed and efficiency. With explosion in biomedical data, data sharing and analysis platforms have surged. AI technologies are moving to the next phase of advancements, and when combined with other emerging tech areas, AI is expected to witness a full fledged adopt...
$4,950.00
Special Price $3,712.50 save 25 %
-
06 May 2016  |  Asia Pacific  |  Market Research
Global Generic Pharmaceuticals Market, Forecast to 2020
Market Participants Target High Value-added Branded Generics and Biosimilars Segments
The key objectives of this research service are to gain an in-depth knowledge of the major markets and therapeutic areas and organizations presenting significant growth opportunities for generics, to understand the impact of regulation on the market, and to outline the industry consolidation trends that will continue shaping the future of generics....
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Apr 2019  |  Global  |  Market Research
Artificial Intelligence—Top 10 Applications in Healthcare, Global, 2018–2022
Exploring Key Investment Trends, Companies-to-Action, and Growth Opportunities for AI in the Healthcare Industry
Artificial intelligence (AI) is exhibiting real promise across multiple industries. The healthcare industry is leading the charge when it comes to focused AI application development and attracting AI investment globally. With improvements in healthcare data acquisition and computing power, AI is becoming more of a reality each day. Frost & Sullivan...
$1,500.00
Special Price $1,125.00 save 25 %
-
12 Apr 2017  |  Global  |  Technology Research
Therapeutic Breakthroughs in Alzheimer’s and Parkinson’s Diseases
Disease-Modifying Treatments Likely to Transform the Clinical Management of Alzheimer’s and Parkinson’s Diseases
The research service primarily encompasses comprehensive analyses of key emerging therapies across AD and PD.The service includes treatment overviews, emerging therapeutic platforms, IP and funding analysis, and emerging innovation profiles across Alzheimer's and Parkinson's diseases. Furthermore, the research service features the impact of key t...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Jul 2024  |  Global  |  Technology Research
Engineered Antibody Therapeutics for Cancer
Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies
This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...
$4,950.00
Special Price $3,712.50 save 25 %